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Abstract
Minorities are disproportionately affected by HIV/AIDS in the rural Southeast; therefore, it is
important to develop targeted, culturally appropriate interventions to support rural minority
participation in HIV/AIDS research. Using Intervention Mapping, we developed a comprehensive
multilevel intervention for service providers (SPs) and people living with HIV/AIDS (PLWHA).
We collected data from both groups through 11 focus groups and 35 individual interviews.
Resultant data were used to develop matrices of behavioral outcomes, performance objectives and
learning objectives. Each performance objective was mapped with changeable, theory-based
determinants to inform components of the intervention. Behavioral outcomes for the intervention
included: (a) Eligible PLWHA will enroll in clinical trials; and (b) SPs will refer eligible PLWHA
to clinical trials. The ensuing intervention consists of four SPs and six PLWHA educational
sessions. Its contents, methods and strategies were grounded in the theory of reasoned action,
social cognitive theory, and the concept of social support. All materials were pretested and refined
for content appropriateness and effectiveness.
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HIV/AIDS disproportionately affects racial and ethnic minorities in the United States with
these groups representing the majority of new AIDS cases (71%), new HIV infections
(67%), people living with HIV/AIDS (PLWHA) (67%), and AIDS-related deaths (70%)
(CDC, 2008; The Henry J. Kaiser Family Foundation, 2009). African Americans and
Latinos have the highest rates of new HIV infections and AIDS cases by race/ethnicity(The
Henry J. Kaiser Family Foundation, 2009). This disparity is further magnified in the South,
which accounts for about half (46%) of new AIDS cases and had the highest number of
PLWHA (40%) (CDC, 2009), with higher rates in poor, often rural areas (Hall, et al., 2008;
Reif, Geonnotti, & Whetten, 2006).
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Similar to trends observed in cancer-related and other disease-specific clinical trials, racial
and ethnic minorities are underrepresented in HIV clinical trials despite the higher disease
burden they carry (Corbie-Smith, Thomas & St. George, 2002; Floyd et al., 2010; Ford et
al., 2008; Sengupta et al., 2000; Sullivan, McNaghten, Begley, Hutchinson, & Cargill,
2007). Factors that hinder participation in other types of research, such as mistrust of
government and research institutions, low health literacy, beliefs about limited benefits from
results, and lack of information about trials also adversely influence participation in HIV
research and clinical trials (Corbie-Smith et al., 2002; Corbie-Smith, Thomas, Williams &
Moody-Ayers, 1999; El-Sadr & Capps, 1992; Floyd et al., 2010; Volkmann, Claiborne, &
Currier, 2009). PLWHA residing in rural areas also face unique barriers to participating in
research such as geographic isolation from major medical centers where HIV clinical trials
take place and limited information about research opportunities (Gifford et al., 2002;
Sengupta et al., 2000). Limited or lack of diversity of clinical trial study participants hinders
investigators' ability to identify possible treatment effects that may differ across racial or
ethnic groups or make suitable inferences due to limited generalizability.
In rural areas, local HIV/AIDS service providers (SPs) are critical in providing care and
therefore may be the only trusted source of information on research opportunities
(Volkmann et al., 2009). The trust between patients and SPs is an important factor in
increasing participation in research (Crawley, 2001; The Henry J. Kaiser Family
Foundation, 2009). In fact, patients who had spoken with their primary provider about
clinical trials in the past are more likely to consider participation and enroll in an HIV
clinical trial compared to those who have not spoken with their provider (Volkmann et al.,
2009). Rural providers may lack information about the availability and importance of their
patients' participation in HIV clinical trials (Kaluzny et al., 1993), which limits the extent to
which these opportunities are made available to potentially eligible participants. Without
access to accurate information about clinical trials from local providers, the possibility of
participation in clinical trials for rural minorities is further diminished.
The rising rates of HIV/AIDS prevalence and incidence among racial and ethnic minority
populations in rural areas coupled with factors limiting representation of these populations
in HIV research and clinical trials heighten the need for innovative interventions to increase
awareness and acceptance about HIV clinical trials (Hall et. al, 2008; Reif et al., 2006;
Sengupta et al., 2010; Whetten et al., 2006). To meet this need, we describe the process of
using Intervention Mapping (IM) to develop a multilevel intervention that engages PLWHA
and their local HIV/AIDS care and SPs to increase awareness and acceptance of HIV
clinical trials and provides practical skills for accessing HIV clinical trials and referring
PLWHA to participate in such opportunities.
Method
Our intervention was designed as part of an ongoing community-based research study,
Project Education and Access to Services and Testing (EAST). Project EAST was conducted
in six counties in the Southeastern United States that have high poverty levels, and an
average income and high school graduation rate below the state average (MDC, 2010; U.S.
Census Bureau, 2010). These communities also bear a burden of HIV/AIDS above the 50th
percentile for the state, with significant racial and ethnic disparities in HIV incidence and
prevalence (N.C. Division of Public Health: Communicable Disease Branch, 2008). A
Community Advisory Board (CAB) worked with Project EAST in the development,
evaluation, and implementation of the intervention. CAB members consisted of
representatives from a range of sectors (e.g., churches, schools, AIDS service and health
organizations, and city government) as well as PLWHA.
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IM comprises a series of steps in intervention planning, implementation, and evaluation
(Bartholomew, Parcel, Kok, & Gottlieb, 2011). Within each step are specific tasks aimed at
producing theory-driven, evidence-based interventions. This series of steps facilitate a
systematic and iterative process of intervention development and adaptation as researchers
move back and forth between tasks and steps. Below is a description of the methods used to
complete the first four IM steps.
Step 1: Literature Review and Formative Research on Needs and Assets
Step 1 involves conducting a review of the existing literature as well as collecting formative
data regarding the select community's needs, strengths and their capacity. Prior to planning
the EAST intervention, we explored the behavioral and environmental factors that led to
underrepresentation of minorities in HIV research through a comprehensive literature
review. We also conducted 11 mixed gender focus groups (10 English, 1 Spanish) with HIV/
AIDS care and SPs who provide direct clinical care or services to PLWHA (n= 40), and
conducted individual interviews with 35 PLWHA (30 English, 5 Spanish). We developed
the guides for the focus groups and the interviews with intentional overlap to allow for
triangulation of findings. Drawing from the findings in the literature review, the guides
contained questions regarding personal and community views about and experiences with
HIV/AIDS; perspectives on research and HIV/AIDS clinical trials; and thoughts regarding
how to introduce HIV clinical trials into the community. Focus group moderators and note-
takers were either African American or Latino women. Bilingual, bicultural research staff
conducted all of the Spanish focus group and individual interviews. Detailed methods and
results are fully described elsewhere (Corbie-Smith, Roman Isler, Shandor Miles & Banks,
2010; Roman Isler, Shandor Miles, Banks & Corbie-Smith, in press; Sengupta et al., 2010;
Shandor Miles, Roman Isler, Banks, Sengupta & Corbie-Smith, 2010). We used these data
to establish behavioral outcomes for both SPs and PLWHA.
Step 2: Developing Matrices of Objectives
Step 2 includes developing matrices of behavioral outcomes (i.e., intervention goals) based
on the integration of socio-behavioral theories with data collected in Step 1.
Theoretical Frameworks—Based on the review of the literature and the qualitative
formative data, we grounded the EAST intervention in the Theory of Reasoned Action
(TRA), Social Cognitive Theory (SCT) and the concept of Social Support (SS) (Bandura,
2002; Fishbein et al. 1979; Fishbein & Ajzen, 1980; Fishbein & Middlestadt, 1989;
Fleishman et al., 2000). TRA postulates that health-related behavior is a function of
behavioral intention, which is influenced by a person's attitude towards performing a
behavior and beliefs about whether individuals important to the person approve or
disapprove of the behavior (Ajzen, 1991; Fishbein & Ajzen, 1980; Fishbein & Middlestadt,
1989). Behavioral intention is the strongest predictor for a given behavior, in this case,
referral to or enrollment in an HIV clinical trial (Figure 1). SCT describes a dynamic,
ongoing process in which intrapersonal and environmental factors, and human behavior
exert influence upon each other i.e., the principle of reciprocal determinism (Bandura, 1998;
Bandura, 2002). For EAST, we identified self-efficacy, behavioral capacity (knowledge and
skills), and outcome expectations as important determinants of behavior change (El-Sadr &
Capps, 1992; Freedberg et al., 2001; Gwadz et al., 2010a). Lastly, we incorporated the
concept of social support as a function of one's social network which influences attitudes
and behaviors relating to HIV clinical trial opportunities (El-Sadr & Capps, 1992; Gwadz et
al., 2010a; Volkmann et al., 2009). Social support is one of the functions of an individual's
social network. There are four main types of social support: informational, instrumental,
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appraisal and emotional (Glanz, Rimer, & Viswanath, 2008). These are conceptualized in
relation to HIV clinical trial participation. For example, a SP may provide informational
support by providing reading materials or brochures on the importance rural minority
participation and HIV clinical trials and possible avenues for locating clinical trial
opportunities, while a PLWHA could assist another PLWHA with instrumental support such
as child-care during clinical trial appointments (Fleishman et al., 2000; Gwadz et al., 2011;
House, 1981).
Developing Matrices—Based on Step 1 findings and guided by the theoretical
framework, the EAST research team and the CAB jointly worked on specifying performance
objectives, behavioral determinants and learning objectives important in changing desired
behavioral outcomes (i.e., intervention goals). Learning objectives state what needs to be
achieved in order to reach performance objectives that will then enable an individual to
attain behavioral outcomes identified in Step 1. Behavioral determinants are constructs,
derived from health behavior theory that may affect desired outcomes (Bartholomew et al.,
2011). We developed matrices with performance objectives arranged in rows and behavioral
determinants organized in columns for each behavioral outcome. In each matrix cell, the
learning objectives indicate what needs to be learned or changed to achieve a particular
performance objective. For example, in order for a PLWHA to meet the performance
objective, “talk with a referral source regarding clinical trial opportunities and
participation”, they should demonstrate certain skills. Each learning objective within the
“skill” cell for this performance objective responds to: “What skills are needed to talk with a
referral source regarding clinical trial opportunities and participation?”
Step 3: Select Theory-based Methods and Strategies
Step 3 involves specifying intervention methods and practical strategies for achieving each
learning objective. Theory-based intervention methods and strategies are linked to the
learning objectives listed in Step 2 (Bartholomew et al., 2011). A method is a process for
influencing changes in behavioral determinants. A strategy is a specific technique for the
application of theoretical methods in a manner that fits the context in which the intervention
will be implemented and the prioritized population. For instance, a theory-based method for
addressing a SCT determinant—skills for overcoming barriers to clinical trial participation
—could be guided practice with a corresponding strategy of participant role play.
Step 4: Produce Program Components and Materials
Step 4 includes producing and pretesting program components and materials. This step
involves organizing strategies into tangible deliverables such as the actual design of the
intervention, implementation training manuals, and supplementary materials. As part of this
task, we determined the program structure (i.e., scope and sequence), channels for delivery,
educational session content and supplementary materials. Consultation with our CAB and
qualitative data collected in Step 1 were used to design the content and format of the
intervention materials.
Pretest of Program Components and Materials—We pretested all intervention
materials for content appropriateness and effective delivery. First, our CAB reviewed all
content and provided specific feedback on group activities. In addition, preliminary SP
intervention materials were pretested with seven allied health students, at a southeastern
university, with backgrounds in nursing, social work and/or public health. These individuals
represented the type of SP in the project communities. For the PLWHA intervention pretest,
we recruited eight participants from a support group for HIV positive individuals at a local
county health department. The goals of the pretest were to (1) test initial program concepts
proposed to portray main ideas, (2) determine whether program components are attended to,
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comprehended, appealing and culturally relevant, and (3) identify potential problems with
implementation (Bartholomew et al., 2011).
Observation guides were developed to record the extent to which the sessions were executed
as planned. These guides included timings for each activity, questions about participants'
level of engagement and facilitators' delivery, logistical issues, materials used, and any
changes to the sessions such as omission or modification of activities. Notes were recorded
for refinement of the intervention materials. We audio-taped debriefings with the session
facilitators, observers and note-takers after each session in order to account for all
perspectives Furthermore, a short satisfaction survey with questions about content and mode
of delivery was administered to participants after every session. Lastly, a focus group
discussion was conducted by a member of the research team after the last session to allow
for feedback from participants about the flow of the sessions, satisfaction with session
activities and appropriateness of supplementary materials.
Results
Step 1: Formative Research on Needs and Assets: Literature Review, Focus Group and
Individual Interviews
In our review, we found limited literature describing the impact of interventions to increase
the participation of minority PLWHA in HIV/AIDS clinical trials (El-Sadr & Capps., 1992;
Freedberg et al., 2001; Gwadz et al., 2010a; Gwadz et al., 2010b; Gwadz et al., 2011;
Volkmann et al., 2009). Of the available studies, we found concordance with the factors
described by our CAB and in our formative work (described below) that may influence
minority participation in HIV clinical trials in the rural communities in which we were
working. For example, all of the studies sought to increase awareness of and opportunities to
participate in HIV clinical trials for PLWHA. These critical concepts have been articulated
in efforts to increase diversity in cancer clinical trials (Ford et al., 2008) and were evidenced
in the reports of HIV clinical trial interventions. These interventions included either
videotapes or one-on-one sessions with PLWHA by either research staff, outreach workers
or trained peers to increase knowledge of HIV clinical trials and change attitudes about
participation in HIV clinical trials (El-Sadr & Capps., 1992; Freedberg et al., 2001; Gwadz
et al., 2011). In addition, two studies explicitly addressed the importance of the social
networks either through peers or engagement of SPs (Gwadz et al., 2011; Volkmann et al.,
2009). All of the interventions either explicitly or implicitly addressed non-trial related
factors that may hinder HIV participation for minorities (El-Sadr & Capps, 1992; Gwadz et
al., 2011; Volkmann et al., 2009). However, none of these studies were conducted in rural
communities where the HIV epidemic is increasing at alarming rates. Additionally, none of
the studies mentioned the engagement or involvement of a CAB. Although one study used a
theoretical approach to inform intervention development, the intervention did not include
SPs. Nonetheless, these studies informed our choice of behavioral and environmental
determinants of rural minority participation in HIV clinical trials. In addition to determinants
from SCT, other studies indicate the following factors affecting minority participation in
HIV clinical trials: knowledge, skills and self-efficacy of both SPs and PLWHA and support
of SPs before and during enrollment in HIV clinical trials.
Coupled with the literature review, findings from the formative qualitative research revealed
several barriers to clinical trial participation that we also considered in the development of
the intervention (Table 1). Most respondents indicated a lack of information about clinical
trials and clinical trial opportunities. Many PLWHA respondents conflated HIV clinical
trials with regular HIV care despite the verbal and written definitions that were given to
respondents during the individual interviews. Lack of transportation, distance from major
tertiary care centers, stigma and concerns about breeches of confidentiality were recurrent
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themes among SP and PLWHA, as rural communities are characterized as having small,
overlapping social networks. Table 1 displays findings and intervention recommendations.
The EAST intervention was originally conceived as a single, one-on-one informational
session with PLWHA considering participation in a clinical trial; however, based on our
findings and their knowledge of the community, the CAB strongly suggested changes in the
format for several reasons. First, they stated the short duration of the one-on-one session
would not provide enough time for PLWHA to fully comprehend the basics of clinical trials
and the complexities of trial participation. They also felt SP need to be educated about HIV
clinical trials before PLWHA in order for them to be able to support PLWHA and answer
questions during the decision-making process. The final suggestion was to develop multiple
sessions for both groups in order to give participants an opportunity to digest the
information and have questions answered by EAST research staff. Based on the literature
review and qualitative data, we arrived at the following behavioral outcomes for PLWHA
and SP: (a) eligible PLWHA will enroll in clinical trials and (2) SPs will refer eligible
PLWHA to clinical trials.
Step 2: Matrices
Formative data from Step 1 and findings from the literature review shaped EAST's agenda
with respect to how objectives should be prioritized and addressed by the intervention.
Using an iterative process between research staff and CAB members, we developed two
matrices addressing behavioral outcomes for PLWHA and SP: (a) Eligible PLWHA will
enroll in clinical trials, and (b) SP will refer eligible PLWHA to clinical trials. For each
matrix, performance objectives were listed in rows to the left while behavioral determinants
were added as column headings. Learning objectives were then organized within cells of
each matrix by each theory-derived behavioral determinant and performance objective.
Table 2 shows a section of the matrix for behavioral outcome, “PLWHA will enroll in HIV
clinical trials” and illustrates two related performance objectives: “Talk with a referral
source regarding clinical trial opportunities and participation” and “Gather ancillary support
for participation in clinical trial (transportation, support system, etc.)”.
Step 3: Theory Based Methods and Strategies
Methods and strategies were selected to influence SPs and PLWHA to meet the learning
objectives identified in Step 2. For example, in the development of SP and PLWHA sessions
focusing on eliciting support, information and guided practice were selected as methods for
discussing the importance of social support and how to identify and build different types of
support before, during and after clinical trial participation. Strategies employed included
demonstrations illustrating the four types of social support and a facilitated exercise where
participants practiced identifying people and organizations that can provide such support.
Each learning objective was aligned with methods and strategies that prompted a change in
the associated behavioral determinants (knowledge, skills, self-efficacy, attitudes, outcome
expectations and social support). We grouped learning objectives based on the identified
behavioral determinants and then selected activities that would help fulfill them. For
example, the first two learning objectives state that: “Providers will be able to describe their
role in discussing clinical trial opportunities” and “Identify effective and ethical approaches
to helping PLWHA make decisions about clinical trials”. These objectives relate to the
behavioral determinants—knowledge and skills—as found in the behavioral capacity
construct of the SCT. Some methods for fulfilling these objectives include providing
information, vicarious reinforcement, and skills training with guided practice and feedback.
We applied strategies such as a PowerPoint presentation that detailed the basics of HIV
clinical trials in addition to roles SPs could serve in to support eligible PLWHA
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participation in clinical trials. We also created skits that depicted effective communication
about clinical trial participation between SP and PLWHA, and used role plays with feedback
to build skills in starting these types of conversations.
Intervention sessions and associated materials employed adult learning theory, social
learning and cognitive behavioral approaches, such as guided practice for identifying and
overcoming barriers to trial participation, and self-efficacy in attaining goals and skills
(Bartholomew et al., 2011). Active learning was emphasized using a variety of theory-based
strategies such as role plays, and skits.
Step 4: Program Components and Materials
We developed one intervention for SP and another for PLWHA. The four SP sessions were
small group, facilitator-led sessions that focused on knowledge about HIV clinical trials,
locating trial opportunities, and supporting PLWHA before, during and after participation in
a clinical trial. The duration of these sessions ranged between 60 and 70 minutes. The six
PLWHA small group, facilitator-led sessions covered similar content with more emphasis
on skill-building for identifying and overcoming barriers to trial participation and also
included more activities on research participants' protection during clinical trial participation
(Table 3). PLWHA sessions were slightly longer than SP on average, with duration of
sessions ranging from 50 to 90 minutes.
There was intentional overlap in the content and format of the SP and PLWHA sessions;
however, we customized the materials to fit the themes that emerged from our formative
research as well as the needs of each group (Table 3). In addition, SP received a total of four
newsletters reinforcing key content from the sessions while PLWHA received four flyers
detailing example questions asked during trial participation, general information about HIV
clinical trials, what they entail, how to locate them and how participants' rights are protected
in a clinical trial.
The focus group discussions conducted during pretests of the intervention provided valuable
information about areas for revision and improvement for each respective group receiving
the educational sessions. For the SP pretest, participants were all female, ages 23 to 33
(n=7), three were African American, three European American, and one Asian. All
participants had at least a college degree; four were full-time nursing students, of which only
one had experience in the field of HIV/AIDS. Others included a researcher/educator with
nine years of experience in HIV/AIDS work, a university-level educator with one year of
experience, and a nursing assistant with no HIV/AIDS-related experience. At baseline,
participants reported a high level of knowledge regarding HIV clinical trials, with each
scoring over 90% on the 42-item knowledge questionnaire. They also expressed positive
attitudes about their roles relating to clinical trial participation: to inform, problem-solve and
support their patients before, during and after clinical trial participation.
The PLWHA pretest group consisted of five males and two females (n=7), ages 20 to 70; all
self-identified as African American. All participants reported at least a high school diploma/
GED, five reported some college education, four had never been married and one was
employed. All but one participant reported health insurance through Medicare, Medicaid or
other programs. At baseline, participants were knowledgeable about HIV clinical trials, with
over 70% responding correctly to questions about the purpose and function of clinical trials,
how they are conducted, and how participants' rights are protected.
Program Concepts' Portrayal of Main Ideas—During the SP sessions, we tested
program materials to portray key ideas such as our presentation of what a clinical trial is,
types of clinical trials and how to inform, listen, problem-solve and support patients from
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referral through participation in a clinical trial. Overall, we successfully conveyed these
messages; participants provided additional feedback –recommending the language be kept
simple and consistent throughout all the SP sessions for better comprehension, clarity and
coherence. In the PLWHA sessions, we tested the same key concepts but placed greater
emphasis on making an informed decision regarding clinical trial participation, protecting
confidentiality and eliciting support before, during and after clinical trial participation.
Positive feedback from participants confirmed that these main ideas were portrayed as
originally conceptualized.
Comprehension and Cultural Relevance of Program Components—Although SP
and PLWHA participants were highly satisfied with the overall content and delivery, they
offered substantial feedback on which activities worked well and which materials should be
removed or modified. Their feedback helped us refine and develop the final intervention
components. For example, SP and PLWHA pretest participants were dissatisfied with a
commercially available video that emphasized the importance of racial and ethnic minority
participation in clinical trial research. They were frightened at the sight of large medical
equipment and laboratory materials and were also confused by what appeared to be a
complex process of navigating through the referral to participation process for potential
participants. Hence, we replaced this video with a testimonial of an African American
PLWHA from a comparable, rural area who has participated in several clinical trials.
Implementation Issues—We identified the need for more support personnel such as
note-takers and co-facilitators. The co-facilitator would serve as a back-up in case of any
unforeseen events, and assist the lead facilitator with session activities. Note-takers would
help capture information about the physical set-up of the room, participants' engagement
level, any changes in program content and delivery of materials, and assist the facilitator as
needed. To this end, a four-day facilitator training workshop was created to train staff
members to be effective facilitators, co-facilitators and note-takers.
In addition, we noted that SP participants took longer to complete the paper-based baseline
survey than anticipated (20–40 minutes); hence, we added a short introductory session to
obtain informed consent and administer the baseline survey with SP. Given this observation,
we decided to use audience response system with PLWHA in anticipation that we would
face the same issue, particularly given varying literacy levels. To administer the baseline
survey in PLWHA sessions using the audience response system by TurningPoint, the
facilitator read the survey items aloud and participants select their answer to each question
using a handheld device.
We also realized the need for more time for participants to ask questions and share their
concerns or experiences. Therefore, we increased the amount of time allocated to each
activity and used a flipchart sheet (“Parking Lot”) to record questions or concerns that
would need to be addressed at a later time. Also, we adjusted the sequence of activities in
the sessions in order to fully devote the last session for both PLWHA and SP to questions
and answers about what to expect during clinical trial participation.
Discussion
We used IM to systematically develop a multilevel intervention aimed at increasing rural
racial and ethnic minority participation in HIV clinical trials. To our knowledge, this is the
first multi-level, multi-modal, theory-driven and community-based intervention developed
to address the underrepresentation of rural minorities in HIV clinical trials. Initial formative
research and ongoing consultation with the EAST CAB yielded data that drove the
development of four facilitator-led small-group sessions for SP and six corresponding
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sessions for PLWHA which were pretested among populations demographically similar to
the intended study participants.
IM has proven effective in the development and adaption of several other HIV/AIDS-related
interventions (Corbie-Smith et al., 2010; Côté, Godin, Garcia, Gagnon & Rouleau, 2008;
Kesteren, Kok, Hospers, Schippers & Wildt, 2006; Kok, Harterink, Vriens, de Zwart, &
Hospers, 2006; Mkumbo et al., 2009; Mukoma et al., 2009; Ramirez-Garcia & Côté, 2009;
Tortolero et al., 2005; van Empelen, Kok, Schaalma & Bartholomew, 2003). This structured,
iterative process promotes transparency in program developers' steps and tasks from design
through evaluation while allowing for the intervention to be both theory-based and inclusive
of stakeholder perspectives. We found this beneficial for the development of EAST
intervention materials, as intervention components were culturally acceptable and
representative of the study participants' needs. IM also allowed for a smoother translation of
relevant materials from the SP sessions to the PLWHA sessions and vice versa.
Paired with the strengths of IM are a few limitations. First, the IM process can be resource
intensive and therefore may be less feasible in nonacademic settings. Staff members have to
be trained to execute each step and to be aware of what each associated task means within
the context of their specific intervention. Furthermore, it takes a significant amount of time
to conduct a thorough literature review and formative research from which matrices'
contents are derived. Identification of relevant theories also requires familiarity with
sociobehavioral theories and how methods and strategies can be applied to the intervention's
learning objectives. Therefore, it is advisable to build on previous studies that have
employed IM in program planning, implementation, and evaluation as leverage to cost-
effective and time-efficient application of the IM process or identifying key aspects that can
be focused on.
It is also important to note that as we were developing this intervention, there were some
important changes in the socio-political context statewide. Major changes to the AIDS Drug
Assistance Program limited availability of HIV medications for PLWHA and left some
PLWHA with clinical trials as the only way to receive HIV/AIDS treatment. In addition,
local administrative challenges because of the economic recession, such as downsizing at
some clinics, emerged, which hindered collaboration, necessitated pretest in urban areas, and
forestalled our overall progress through the IM steps. These changes to the sociopolitical
context can add greater financial strain on already limited resources, particularly in rural
communities. Therefore, to limit additional stress on potential future users of the program,
we designed the intervention in a manner that could be integrated into existing clinic
administrative structures, such as staff meetings, or used as a series of workshops for
PLWHA in settings such as support groups. Such contextual issues should be integrated
within the current IM guidelines, and program planners would need to be flexible and make
adjustments as needed. It is especially important in the context of HIV/AIDS research and
with ongoing changes in policies governing healthcare financing and organization that
would affect any intervention being tested or disseminated in real-world settings.
Despite these limitations, the IM approach still yielded this comprehensive multilevel
intervention that can be adapted to fit other contexts. Public health practitioners might begin
with reviewing scientific articles on the application of the IM approach to their specific topic
of interest and follow existing models for evidence tables illustrating literature search and
key findings, sample matrices of behavioral outcomes, determinants, performance objectives
and learning objectives. Program adaptation can be easily facilitated given the detailed,
systematic lay out of each planning step to reach final program materials. IM short courses
and intensive seminars are also gaining ground and may be beneficial to public health
professionals with limited expertise in this area.
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In conclusion, IM provided a structured and transparent approach for developing an
important intervention aimed at increasing participation of rural, racial and ethnic minorities
in HIV research and clinical trials. Given the high rates of HIV infection among these
populations, this project has the potential of addressing the principles of equity and justice in
research by addressing the need to advance scientific knowledge surrounding HIV/AIDS
treatment through minority participation in HIV clinical trials. Through the iterative
processes of IM and our collaboration with the EAST CAB, our project resulted in well-
refined program content and we identified core components and appropriate delivery modes
that are culturally relevant to the population. The next phases of intervention development
will be pilot testing the intervention with SP and PLWHA living in rural communities to
assess the impact of this intervention on minority participation in HIV clinical trials.
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Table 1
Results from Formative Research and Intervention Recommendations
Theme Intervention Recommendation Illustrative Quote
Service Providers
 Lack of information about
clinical trials and clinical trial
opportunities
Inform providers about opportunities through
brochures, local resources and the web
“Making sure the private providers in the county
know about the clinical trials and you can't just give
[the information] to them one time and walk off.
You've got to keep going back to them and going
back to them and going back to them.”
 Limited access and/or capacity
to conduct clinical trials research
in rural areas
Introduce clinical trial site personnel to staff at
local clinics and hospitals to foster partnerships
and elicit support
“Any clinical trial you hear about oh, Harvard or
Cambridge … upper crust scientific communities …
you don't think of [this area] and the brothers and the
sisters participating in clinical trials down at the
health department or community clinic.”
 High levels of HIV stigma in
rural communities that can impact
on PLWHA participation
Keep stigma and confidentiality for PLWHA a
theme throughout the intervention program.
“HIV in the eastern part of the state still carries a
very strong stigma and people…who have been
identified as positive are immediately--in many
cases--ostracized even to the point of their families.”
 Lack of familiarity with the
referral process and concern about
losing their patient as part of their
regular care
Provide a handout depicting the CT process from
referral to participation.
“You can't really care for the patient if you don't
know what's going on. So that's one of the big
concerns. Would [clinical trial staff] be willing to
share that with the providers because they're
obviously not the [primary care] providers…”
Describe local service providers' roles in the
referral and participation process
People Living with HIV/AIDS
 Conflated HIV clinical trials
with regular HIV care
Explain the continuum of HIV care (prevention,
testing, research and care)
Have you ever been asked to participate in a clinical
trial or drug study for HIV?
“Like [the interview] we're doing here. [My doctor]
said I've got this new cocktail for you. He asked me
if I wanted to try it and I said yeah and so far I had
no problems with it…he said well it's the same thing
you're taking now but it's all mixed in one.”




Help them identify barriers and solutions to
barriers commonly faced by participants from
rural communities
“See transportation is a big problem [for] rural
areas…they cannot afford to go back and forth for
that…even me…I couldn't afford to go back and
forth to clinical trials”
 Noted fears associated with
participation, including
experimentation and being used as
guinea pigs
Educate potential participants about clinical trials
research, their rights (informed consent), and
how institutions and organizations are required to
protect their rights (IRB and DSMB)
What comes to mind when I say HIV/AIDS clinical
trials?
“They want to take me into a clinic and use me as a
test specimen or something…all thoughts and animal
thoughts. Guinea pig”
 Fear of breaches in
confidentiality and privacy among
research study staff, but also local
medical staff as well
Explain ways that research staff protect
participants' confidentiality, as well as help them
identify ways that they as participants can protect
their confidentiality
What are some things that might cause you to not
trust research or the research process?
“Probably the confidentiality factor due to fact that
most of the time you all probably have computers
and stuff like that…anybody could have access to
that computer…even though you say it's secured but
(chuckle) anybody can get in them, find your files.”
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Table 2
Intervention Mapping Partial Matrix: Learning Objectives for Behavioral Outcome “PLWHA will enroll in
HIV clinical trials”
Performance Objective Knowledge Skills Self-Efficacy Attitudes Outcome Expectations Social Support
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Table 3
Overview of Final PLWHA and SP Intervention Sessions
PLHWA SPs
Session 1: Clinical Trials 101 Session 1: Clinical Trials 101
 Presentation: Overview of Project EAST  Presentation: Overview of Project EAST
 Discussion: Clinical Trials Defined  Presentation: Clinical Trials Basics PowerPoint
 Presentation: CT Basics PowerPoint -Part 1  Activity: Referral 101: Exploring the Types of CTs
 Follow-Up Flyer: Important Facts about Clinical Trials  Skit: Informing Your Client About Clinical Trials
 Follow-Up Newsletter: Provider Series: Session 1
Session 2: Referral and Types of Trials Session 2: Provider-Client Communication About CTs
 Presentation: HIV CT Participant Testimonial Video  Video: HIV CT Participant Testimonial Video
 Activity: Exploring the Types of Clinical Trials  Presentation: Referral to Participation
 Activity: Referral to Participation  Activity: Clinical Trial Jeopardy
 Skit/Role Play: Communication Show and Practice
 Homework: Locating CT Opportunities
 Follow-Up Newsletter: Provider Series: Session 2
Session 3: Overcoming Barriers To CT Participation Session 3: Locating CT Resources: Where Do I Go?
 Presentation: CT Basics PowerPoint-Part 2  Activity: Locating Clinical Trial Opportunities
 Activity: Informed Consent Exercise  Activity: Circle of Connections: Establishing Networks with
Other Providers
 Activity: “Break the Barrier”: Overcoming Barriers to CT
Participation
 Role Play: Discussion with a Referral Source
 Homework: “ Ask the Experts”
 Follow-Up Flyer: Where to Find CT Opportunities  Follow-Up Newsletter: Provider Series: Session 3
Session 4: Support: What Is It And Where Can You Get It? Session 4: Synthesis Of Information
 Activity: Support: What it Means to You  Activity: “Break the Barrier”: Overcoming Barriers to CT
Participation
 Activity: Circle of Connections  Discussion: “Ask the Experts”: What Happens to My Client
During the Trial?
 Skit: Seeking Family Support  Role Play: Talking with Your Client about Clinical Trial
Participation
 Homework: Locating Clinical Trial Opportunities (Scavenger Hunt
Sheet)
 Follow-Up Newsletter: Provider Series: Lesson 4
Session 5: Clinical Trials: What Should You Expect?
 Activity: Scavenger Hunt Reflections
 Role Play: Communicating with Your Provider
 Discussion: Protecting Your Confidentiality
 Homework: “Ask the Experts”
 Follow-Up Flyer: Frequently Asked Questions about Clinical Trials
Session 6: Conversation With the Experts
 Discussion: “Ask the Experts”: Real Life Experiences of Clinical
Trial Staff
Note. PLWHA = people living with HIV/AIDS; SP = Service Provider; CT = Clinical Trial
Health Educ Behav. Author manuscript; available in PMC 2014 June 01.
